TWO · 4198.TWO
S&S Healthcare Holding Ltd.
NT$46.00NT$0.00 (0.0%)
S&S Healthcare Holding Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.38% below the high.
Loading market information…
TWO · 8409.TWO · TWD
Stock price, earnings
Quote as of Oct 29, 2026, 06:31 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
EBM Technologies Incorporated’s quoted price sits in the lower half of its reported 52-week range, 27.66% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow EBM Technologies Incorporated’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1988 and headquartered in Taipei, Taiwan, EBM Technologies Incorporated is dedicated to developing and commercializing sophisticated software and integrated solutions for the global healthcare sector. The company's core offerings include a comprehensive suite of Enterprise Picture Archiving and Communication Systems (PACS). This encompasses SoliPACS, designed to unify various radiology, mammography, and dental imaging products; SoliPACS Gateway for seamless DICOM communication; SoliPACS Server, acting as a crucial interface between hospital information systems (HIS), radiology information systems (RIS), and PACS; SoliPACS Web Viewer, enabling medical professionals to remotely access, compare, and utilize DICOM-compliant images; SoliPACS Report for generating customizable diagnostic reports; and the Advanced Server Archive for robust PACS data storage. EBM also leads in mobile diagnostic technology, featuring the UDE (Ubiquitous Diagnostic Environment) App, which transforms an iPad Pro into an all-in-one standalone DICOM server, viewer, display, and AI processing unit. Their extensive MobiPACS portfolio provides a complete mobile imaging ecosystem, including MobiPACS Server for storing and processing images on mobile devices, the MobiPACS App for on-the-go viewing, MobiPACS Web Viewer for accessing images from any internet-enabled device, MobiPACS Share for cloud-based collaboration, and MobiPACS Multi, which supports connecting multiple iPads/iPad Pros for integrated image display. Beyond imaging, EBM provides a range of specialized medical technologies. These include Vital-Sign On-the-Go for real-time patient monitoring; Rad@ for viewing medical-grade images and facilitating diagnoses; a Digital Pathology Scanner that converts physical slides into digital whole-slide images; the AgileRIS App for offline reporting; EPS Pi, a viewer-ready DICOM device; and the UniGate_i (UGI) App. Furthermore, the company delivers essential information management and eHealth solutions. These comprise Telemed, linking medical facilities for enhanced collaboration; Electronic Medical Records (EMR), providing digital versions of patients' medical histories; Personal Health Records (PHR), offering individuals electronic access to their health data; and broader eHealth solutions for retrieving and reviewing patient images, vital signs, and ECG waveforms.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$46.00NT$0.00 (0.0%)
S&S Healthcare Holding Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.38% below the high.
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
NT$14.60-NT$0.35 (-2.34%)
Original BioMedicals Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 27.0% below the high.
NT$15.85-NT$0.20 (-1.25%)
Radiant Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.7% below the high.
NT$16.60-NT$0.30 (-1.78%)
Healthconn Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.97% below the high.
NT$28.35NT$0.00 (0.0%)
BioLASCO Taiwan Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
NT$33.10+NT$0.25 (+0.76%)
Sofiva Genomics Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.25% below the high.
NT$18.65NT$0.00 (0.0%)
TFBS Bioscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.03% below the high.
